699 related articles for article (PubMed ID: 11979553)
21. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia.
La Starza R; Trubia M; Testoni N; Ottaviani E; Belloni E; Crescenzi B; Martelli M; Flandrin G; Pelicci PG; Mecucci C
Haematologica; 2002 Aug; 87(8):789-94. PubMed ID: 12161353
[TBL] [Abstract][Full Text] [Related]
22. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
23. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
[TBL] [Abstract][Full Text] [Related]
24. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
25. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
26. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
27. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
28. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
Batista DA; Hawkins A; Murphy KM; Griffin CA
Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
Van Limbergen H; Beverloo HB; van Drunen E; Janssens A; Hählen K; Poppe B; Van Roy N; Marynen P; De Paepe A; Slater R; Speleman F
Genes Chromosomes Cancer; 2001 Mar; 30(3):274-82. PubMed ID: 11170285
[TBL] [Abstract][Full Text] [Related]
30. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
31. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
Gadzicki D; von Neuhoff N; Steinemann D; Just M; Büsche G; Kreipe H; Wilkens L; Schlegelberger B
Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
[TBL] [Abstract][Full Text] [Related]
32. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
[TBL] [Abstract][Full Text] [Related]
33. Variant e19a2 BCR-ABL1 fusion transcript in typical chronic myeloid leukemia.
Tutulan-Cunita AC; Chirieac SM; Mocanu G; Luca C; Costache M; Lungeanu A; Arghir A
Clin Lab; 2011; 57(9-10):785-8. PubMed ID: 22029197
[TBL] [Abstract][Full Text] [Related]
34. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
35. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
Roti G; La Starza R; Gorello P; Gottardi E; Crescenzi B; Martelli MF; Mecucci C
Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118
[TBL] [Abstract][Full Text] [Related]
36. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
[TBL] [Abstract][Full Text] [Related]
37. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
[TBL] [Abstract][Full Text] [Related]
38. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
[No Abstract] [Full Text] [Related]
39. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
Haigh S; Cuthbert G
Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]